Literature DB >> 26102499

GABA and glutamate: the Yin and Yang of fragile X.

Michael R Tranfaglia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26102499      PMCID： PMC4614528          DOI： 10.1080/15384101.2015.1060782

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

1.  The developmental switch in GABA polarity is delayed in fragile X mice.

Authors:  Qionger He; Toshihiro Nomura; Jian Xu; Anis Contractor
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

Review 2.  The psychiatric presentation of fragile x: evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome.

Authors:  Michael R Tranfaglia
Journal:  Dev Neurosci       Date:  2011-09-02       Impact factor: 2.984

3.  Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice.

Authors:  Lujian Liao; Sung Kyu Park; Tao Xu; Peter Vanderklish; John R Yates
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

4.  Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome.

Authors:  Jay R Gibson; Aundrea F Bartley; Seth A Hays; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2008-09-10       Impact factor: 2.714

Review 5.  Model of autism: increased ratio of excitation/inhibition in key neural systems.

Authors:  J L R Rubenstein; M M Merzenich
Journal:  Genes Brain Behav       Date:  2003-10       Impact factor: 3.449

6.  Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Synaptic Neurosci       Date:  2010-06-07
  6 in total
  1 in total

1.  Sex differences in resting EEG power in Fragile X Syndrome.

Authors:  Elizabeth G Smith; Ernest V Pedapati; Rui Liu; Lauren M Schmitt; Kelli C Dominick; Rebecca C Shaffer; John A Sweeney; Craig A Erickson
Journal:  J Psychiatr Res       Date:  2021-03-31       Impact factor: 5.250
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.